Democrats win control of Congress as health policies face shift
Democratic control of Congress signals a shift in health policy, with new scrutiny on fertility treatments and international medical travel.
(Photo via STAT)
Following the midterm elections, Democrats have secured majorities in both the Senate and the House of Representatives, effectively concluding the Republican trifecta in Washington. This shift in legislative power is expected to alter the trajectory of federal health care policy.
Daniel Payne, a Washington reporter for STAT, noted that the results signal a significant change after two years of extensive modifications to the federal health care infrastructure under the Trump administration. According to Payne, the Democratic victory serves as a hard brake on the pace of changes previously seen at the Department of Health and Human Services and within administration-led private sector initiatives.
The transition in congressional leadership brings new implications for the pharmaceutical and health care industries, as these sectors now face lawmakers with subpoena power. These developments were discussed in a recent episode of the STAT biotech podcast, The Readout LOUD, published on Nov. 6, 2026.
In addition to the broader political shifts, the podcast episode highlighted growing scrutiny surrounding a $30,000 fertility procedure. The discussion also explored the trend of individuals traveling to international fertility clinics for medical care.